Evidence map›Paper›PMID 18784366›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Effects of local mRNA structure on posttranscriptional gene silencing.

Stephen I Rudnick, Jyothishmathi Swaminathan, Marina Sumaroka, Stephen Liebhaber, Alan M Gewirtz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Silencing ofPhysiological genomics · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Fluorescent probes for live-cell RNA detection.Annual review of biomedical engineering · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stephen I RudnickDepartment of Pharmacology, University of Pennsylvania School of Medicine, 421 Curie Boulevard, Philadelphia, PA 19104, USA.
Jyothishmathi Swaminathan
Marina Sumaroka
Stephen Liebhaber
Alan M Gewirtz
University of Pennsylvania · US

Funding

VAV ANTISENSE ODN--A NOVEL THERAPEUTIC FOR HUMAN LEUKEMIASP01CA072765 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GEWIRTZ, ALAN M · 1997 to 2007
$8.5M
UTILIZATION OF TRANSGENIC MICE FOR STUDIES IN SICKLE CELL DISEASEP60HL038632 · NHLBI · CHILDREN'S HOSPITAL OF PHILADELPHIA · PI OHENE-FREMPONG, KWAKU · 1988 to 2002
$6.4M
Alpha-Globin expression: Post transcriptional mechanismsR37HL065449 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LIEBHABER, STEPHEN AARON · 2004 to 2013
$3.9M
Developing Nucleic Acid TherapeuticsR01CA101859 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GEWIRTZ, ALAN M · 2003 to 2007
$1.4M
NCI NIH HHS P01 CA072765NCI NIH HHS P01-CA72765NCI NIH HHS R01 CA101859NCI NIH HHS R01-CA101859NHLBI NIH HHS R37 HL065449
6 · The paper itself

Abstract

Antisense oligodeoxynucleotides (AONs) and short interfering RNAs (siRNAs) effect posttranscriptional gene silencing (PTGS) by hybridizing to an mRNA and then directing its cleavage. To understand the constraints that mRNA structure imposes on AON- vs. siRNA-mediated PTGS, AON- and siRNA-mediated cleavage of defined mRNA structures was monitored in Drosophila embryo whole-cell lysates. We observed that AON-directed cleavage was approximately 3-fold faster than cleavage with a siRNA directed to the same target site. Furthermore, and unexpectedly, AON-mediated cleavage was found to be much less fastidious with respect to target sequence accessibility, as measured by the presence of unpaired nucleotides, than a corresponding siRNA. Nonetheless, in vivo, siRNAs silenced their mRNA target at least 2-fold more efficiently than the corresponding AON. These seemingly contradictory results suggested that additional, as yet undefined factors play an important role in regulating PTGS efficiency in vivo. We used a well defined RNA-binding protein, alphaCP, and its corresponding high-affinity RNA-binding site to explore this hypothesis. We found that prebound alphaCP effectively blocked AON-mediated cleavage of the RNA-binding site compared with cleavage of the site in the absence of alphaCP. We conclude that higher-order structures formed by RNA and bound proteins play an important role in determining the efficiency of AON-directed PTGS. We hypothesize that strategies aimed at removing RNA-binding proteins might significantly improve AON-mediated PTGS in vivo.

Indexed as

RNA InterferenceAnimalsBase SequenceCell LineDrosophila melanogasterHumansMolecular Sequence DataNucleic Acid ConformationOligonucleotides, AntisenseRibonuclease HRNA-Binding ProteinsRNA, MessengerOligonucleotides, AntisenseRibonuclease HRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID18784366
PMCPMC2544532
OpenAlexW2087573072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.